News
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director.
.jpeg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne
We're excited to announce the collaboration of our study with Acinonyx Bio, contributing to the development of their topical cream to treat inflammatory acne.
Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation
This collaboration with University of Oxford explores the perceptions of incentives and barriers to clinical trial participation among both researchers and various underrepresented groups.
Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health’s Advisory Board
Welcoming our newest advisor - Dr. Tim Garnett, former CMO at Eli Lilly!
CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
Announcing our recent collaboration with CLEO Diagnostics for an ovarian cancer detection clinical trial.
Running Effective DTx Studies in EU Markets, and Considerations for Cross Country Data Acceptance
As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.
Interview: Robert Langer backs Lindus Health’s "anti-CRO" strategy
Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.
.png)
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.
Being Nimble and Tech-Forward in Clinical Trial Operations
In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.